Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Voyager Therapeutics, Inc (NASDAQ: VYGR).

Full DD Report for VYGR

You must become a subscriber to view this report.


Recent News from (NASDAQ: VYGR)

Premarket analyst action - healthcare
G1 Therapeutics (NASDAQ: GTHX ) resumed with Buy rating and $80 (31% upside) price target at BTIG Research. More news on: G1 Therapeutics, Voyager Therapeutics, MacroGenics, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: September, 10 2018 07:57
Gene therapy players under pressure
The Nasdaq's selloff notwithstanding, most gene therapy stocks are in the red. This morning, Sangamo Therapeutics ( SGMO -21.1% ) reported data on SB-913 that disappointed investors. More news on: Sangamo Therapeutics, Inc., AVROBIO, MeiraGTx Holdings plc, Healthcare stocks news, Stocks ...
Source: SeekingAlpha
Date: September, 05 2018 10:58
Voyager Therapeutics to Present at Investor Conferences in September
CAMBRIDGE, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe neurological diseases, today announced management presentations at the upcoming investor conferences: Wells ...
Source: GlobeNewswire
Date: August, 28 2018 11:53

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-1419.2319.5519.6518.92294,527
2017-03-1011.8612.4412.6111.7725,703
2017-03-0912.5211.7712.725411.7481,096
2017-03-0813.6312.2713.8012.2179,158
2017-03-0713.7813.5014.4413.4261,884

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-0722,78139,45057.7465Short
2018-12-0614,48544,55132.5133Cover
2018-12-0422,97545,36650.6437Short
2018-12-0312,80833,53238.1963Short
2018-11-3014,16831,97244.3138Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on VYGR.


About Voyager Therapeutics, Inc (NASDAQ: VYGR)

Logo for Voyager Therapeutics, Inc (NASDAQ: VYGR)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $604,199,305 - 05/18/2018
  • Issue and Outstanding: 32,206,786 - 03/09/2018

 


Recent Filings from (NASDAQ: VYGR)

Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: August, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 07 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 07 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 29 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 05 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 29 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 10 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 10 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 27 2018

 

 


Daily Technical Chart for (NASDAQ: VYGR)

Daily Technical Chart for (NASDAQ: VYGR)


Stay tuned for daily updates and more on (NASDAQ: VYGR)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: VYGR)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in VYGR is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of VYGR and does not buy, sell, or trade any shares of VYGR. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/